2026 Regular Session

SB504

Relative to the practice of pharmacy and the dispensing of certain medications by pharmacists, authorizing the establishment of experimental treatment centers, and permitting treatment of certain severe illness under the right to try act.

Chamber Passed·3/27/26

Prefiled

Introduced

Chamber Passed3/27/26

Final Passage

Complete

New Hampshire SB504 establishes experimental treatment centers for severe illnesses.

New Hampshire SB504 amends pharmacy practice laws to authorize experimental treatment centers for patients with terminal or severe illnesses. The bill allows licensed pharmacists to administer experimental treatments and mandates that these centers obtain authorization from the Department of Health and Human Services. It also provides immunity from suit for healthcare providers involved in such treatments if certain conditions are met.

Included in complete analysis

Overview
Core Provisions
Implementation
Impact
Legal Framework
Critical Issues

Analyze for Free

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Last: Passed the Senate · 188–153 · Mar 27
Current: The House
Next: Session adjourned — paused until it reconvenes

SB504

Where it stands

Sponsors

SB504

Where it stands

Sponsors

SB504

Where it stands

Sponsors

SB504

Where it stands

Sponsors

Roll Call Votes

Calendar

History

Roll Call Votes

Calendar

History